The potential role of active music therapy in ameliorating motor and nonmotor symptoms of Parkinson’s disease (PD) was examined by researchers.
News
All but one type of statin was associated with a dose-dependent neurprotective benefit against Parkinson’s.
The drug was generally well-tolerated among study participants.
Patients experienced a 50% improvement in tremor and motor function.
The FDA previously investigated the effects of gadolinium deposits in the brain.
The odd relationship may have more to do with the mental disorder than the drugs.
Critics are warning to not jump to conclusions, as the results may stem from several causes.
The drug is the first of its kind to address PD psychosis without having an ill effect on motor symptoms.
The authors are primarily concerned with the overlap of therapies being used in these patients.
Researchers observed to between-group differences between real and sham treatment.
The need for an effective treatment appeared to sway panelists who expressed reservations about the safety and efficacy of pimavanserin.
Researchers are unsure if the disease itself or the medications are the factor.
The link was between the two conditions, not the medications used to treat rosacea.
Cognitive difficulties may pose greater problem with speech than physical disabilities.
Ischemic heart disease and head injury in those with HCV was associated with Parkinson’s risk.
On-road assessors may not consider a person’s comorbidities when evaluating driving ability.
Researchers from the UK report that PT and OT provide no benefit in patients with mild to moderate Parkinson disease.
Thos who took the drug were 45% less likely to fall compared to those who took placebo.
The association was only observed in men, not women.
The researchers suggest that BMI fluctuation may indicate Parkinson’s disease subtypes.
Parkinson’s patients taking a high and lower level of anticholinergic medications showed no difference in cognition.
OCT can precisely measure changes to the retinal structure.
Patients with hepatitis C were 29% more likely to develop Parkinson’s after accounting for age, sex and other health conditions.
Contaminated milk may contribute to the loss of neurons in the substantia nigra, an early sign of Parkinson’s.
Patients with Parkinson’s had reduced CSF ccf-mtDNA compared to asymptomatic controls.
Using whole-exome sequencing, researchers identified 2 genes with potentially damaging genetic variants that could affect familial Parkinson’s susceptibility.
Those treated with levodopa saw macular degeneration onset later than controls.
If approved, Nuplazid will be the first treatment specifically designed to address PDP.
Acupuncture treatment saw improvements in gait speed, step length, floor reaction force, and cadence.
The FDA found no evidence in support of increased cardiovascular risks with use of entacapone in Parkinson’s.
